학술논문

Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece.
Document Type
Article
Source
Frontiers in Pharmacology; 2023, p01-09, 9p
Subject
CANCER patients
DIHYDROPYRIMIDINE dehydrogenase
GENETIC variation
CANCER chemotherapy
PROGNOSIS
Language
ISSN
16639812
Abstract
Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)